Evolutionary Profile of Opportunistic Infections in People Living with Human Immunodeficiency Virus during Six Months of Dolutegravir Based Antiretroviral Treatment in Kinshasa, Democratic Republic of Congo
Background: Opportunistic infections (OI), which are still a major problem in the care of People Living with HIV (PLHIV), occur in situations of immunosuppression. The AntiRetroViral Treatments (ART) used allow a spectacular reduction in the frequency of Opportunistic Infections. Objective: The objective of this study is to present the evolution of Opportunistic Infections in People Living with HIV under AntiRetroViral Treatment in Kinshasa in the era of Dolutegravir. Methods: The present study is a prospective cohort to present the evolutionary profile of OIs in PLHIV on ART for 6 months in Outpatient Treatment Centers (OTC) in Kinshasa. Sixteen OTCs had been included. The population of the present work was patients over 18 years of age at inclusion, infected with HIV-1 and initiating ART in the selected OTC. Results: On inclusion, 119 patients were included of which 56.3% were women. Malaria (45.4%), tuberculosis (29.4%) and cutaneous pruritus (23.5%) were the most common Opportunistic Infections (OIs). In the third month of ART, 37 patients came for the consultation of which 70.3% were women. Non-specific STIs (97.3%), skin pruritus (37.8%) and malaria (24.3%) were the dominant OIs among patients. At the sixth month of ART, 62 patients came for the medical consultation of which 61.3% were women. Skin pruritus (25.8%), dermatitis (22.6%) and rash (21%) were the most common OIs. Conclusion: The evolutionary profile is marked by the conservation of Opportunistic Infections such as dermatitis (pruritus and rashes) and malaria.
References
[1]
Kamangu, E.N., Bulanda, B.I., Mwanaut, I.M., Makoka, S.K. and Mesia, G.K. (2021) Evaluation of Rational Use of Antiretrovirals before the Dolutegravir Transition in Kinshasa, Democratic Republic of Congo. World Journal of AIDS, 11, 41-49. https://doi.org/10.4236/wja.2021.112004
[2]
Programme National de Lutte contre le VIH/SIDA et les IST (PNLS). Ministère de la Santé Publique. République Démocratique du Congo (2017) Guide National de Prise en Charge intégrée du VIH.
[3]
Programme National de Lutte contre le VIH/SIDA et les IST (PNLS). Ministère de la Santé Publique. République Démocratique du Congo (2019) Révision du Guide National de Prise en Charge.
[4]
Descripteur MeSH: Infections Opportunistes liées au SIDA. CISMeF. https://www.cismef.org/page/infections-opportunistes-la-vie-personnes-vivants-VIH
[5]
Siegfried, N., Clarke, M. and Volmink, J. (2005) Randomized Controlled Trials in Africa of HIV and AIDS: Descriptive Study and Spatial Distribution. BJM, 331, 742. https://doi.org/10.1136/bmj.331.7519.742
[6]
Programme National de la Lutte contre le VIH/SIDA et les IST (PNLS), Ministère de la Santé Publique et Hygiène. République Démocratique du Congo (2009) Actualisation des connaissances sur la carte épidémiologique et les capacités de gestion (prévention et prise en charge) des infections et autres affections opportunistes de l’infection à VIH à Kinshasa et Matadi. Rapport d’Enquête.
[7]
Izzia, K., Kapita, B., Mbendi, N., et al. (1993) Etiologie de la fièvre au cours du SIDA: à propos de 64 cas. https://pesquisa.bvsalud.org/portal/resource/pt/afr-185098
[8]
Kamangu, N.E., Situakibanza, N.H., Mvumbi, L.G., Kakudji, I.L., Tshienda, T.D. and Mesia, K.G. (2012) Profiles of Opportunistic Infections in People Living with HIV Followed at the Military Hospital of Kinshasa Reference (Camp Kokolo), DRC. BMC Retrovirology, 9, P146. https://doi.org/10.1186/1742-4690-9-S1-P146
[9]
Kamangu, N.E., Muhindo, M.H., Wapa-Kamangu, W.C. and Situakibanza, N.T.H. (2015) Prevalence of Malaria Infection among People Living with HIV in Kinshasa. Open Access Library Journal, 2, e1077. https://doi.org/10.4236/oalib.1101077
[10]
Kamangu, E.N. (2016) Human Immunodeficiency Virus Type 1 and Type 2 Co-Infection Rate in Kinshasa Patients. Mathews Journal of HIV/AIDS, 1, Article No. 009.
[11]
Bongenya, B.I., Bulanda, B.I., Bukongo, R.N., Chuga, D., Botomuito, T.H., Kabasele, J.Y.D. and Kamangu, E.N. (2022) Prevalence of Opportunist Infections among the Professionals Sex Workers and their Customers Living with the VIH under ARV in Kinshasa. Open Access Library Journal, 9, e7927. https://doi.org/10.4236/oalib.1107927
[12]
Losenga, O.L., Dikati, M.N., Bongenya, I.B., Ntumba, K.T., Booto, I.G., et al. (2022) Sociodemographic and Anthropometric Profile of People Living with Human Immunodeficiency Virus Starting Treatment in Kinshasa, Democratic Republic of the Congo. Open Access Library Journal, 9, e9056. https://doi.org/10.4236/oalib.1109056
[13]
Ministère du Plan et Suivi de la Mise en œuvre de la Révolution de la Modernité et Ministère de la Santé Publique, République Démocratique du Congo (2014) Enquête Démographique et de Santé 2013-2014 (EDS 2013-2014). Rapport 2014.
[14]
Kamangu, N.E., Bulanda, I.B., Bongenia, I.B., Botomwito, H.T., Mvumbi, G.L., De Mol, P., Vaira, D., Hayette, M.P. and Kalala, R.L. (2015) Virological Profile of Patients Infected with HIV Starting Antiretroviral Treatment in Kinshasa. Open Access Library Journal, 2, e1564. https://doi.org/10.4236/oalib.1101564
[15]
Bulanda, B.I., Kateba, E.T., Bongenia, B.I., Kasongo, V.N., Kingombe, M.A. and Kamangu, E.N. (2018) Sociodemographic and Anthropometric Profile of Positive HIV Patients in Early Traditional Treatment: Case of the Bonkoko Center. Open Access Library Journal, 5, e4555. https://doi.org/10.4236/oalib.1104555
[16]
Buju, R.T., Akilimali, P.Z., Kamangu, E.N., Mesia, G.K., Kayembe, J.M.N. and Situakibanza, H.N. (2022) Predictors of Viral Non-Suppression among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study. International Journal of Environmental Research and Public Health, 19, Article No. 1085. https://doi.org/10.3390/ijerph19031085
[17]
Buju, R.T., Akilimali, P.Z., Kamangu, E.N., Mesia, G.K., Kayembe, J.M.N. and Situakibanza, H.N. (2022) Incidence and Predictors of Loss to Follow Up among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study. International Journal of Environmental Research and Public Health, 19, Article No. 4631. https://doi.org/10.3390/ijerph19084631
[18]
Kamangu, N.E., Wumba, R.D.M., Situakibanza, H.N.T., Lukusa, P.T., Kapend, L.K., Mvumbi, G.L., Hayette, M.P. and Kalala, R.L. (2018) Molecular Epidemiology of Human Immunodeficiency Virus Type 1 and Therapeutic Monitoring of Patients Treated in Kinshasa/Democratic Republic of the Congo. International Journal of HIV and Aids Research, 2, 6-11.
[19]
Mbula, M.M.K., Situakibanza, H.N.T., Mananga, L.G., Longokolo, M.M., Mandina, N.M., Mayasi, N.N., et al. (2020) Profil clinique et biologique des Personnes Vivant avec le VIH/SIDA suivies dans le Service des Maladies Infectieuses des Cliniques Universitaires de Kinshasa, République Démocratique du Congo. Revue Malienne d’Infectiologie et de Microbiologie, 15, 21-29. https://doi.org/10.53597/remim.v15i2.1727
[20]
Kamangu, N.E., Bwiri, B.B. and Mvumbi, L.G. (2019) Clinical and Paraclinical Profile of People Living with Human Immunodeficiency Virus on Second Line Treatment in Kinshasa, Democratic Republic of Congo. Open Access Library Journal, 6, e5499. https://doi.org/10.4236/oalib.1105499
